
In January 2025, the European Medicines Agency (EMA) released a report of its key figures for the authorization of new and biosimilar medicines in 2024. Highlights include groundbreaking treatments...
More >In January 2025, the European Medicines Agency (EMA) released a report of its key figures for the authorization of new and biosimilar medicines in 2024. Highlights include groundbreaking treatments...
More >